Erythropoietin (EPO) and Granulocyte-Colony Stimulating Factor (G-CSF) for Low-Risk Myelodysplastic Syndromes (MDS)
Clinical trial NCT00234143 · UNKNOWN
Trial details
- NCT number
- NCT00234143
- Sponsor
- St. Bartholomew's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.